Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Reviews in Endocrine & Metabolic Disorders
|
June 17, 2025
Exploring obesity phenotypes: a longitudinal perspective
Ricardo Rosero-Revelo, Mateo Tamayo, Ricardo Correa, et al.
International Journal of Endocrinology
|
May 5, 2023
Surgical Management of Giant Prolactinomas: A Descriptive Study
Michelle D Lundholm, Divya Yogi-Morren, Kevin M Pantalone, et al.
Diabetes, Obesity & Metabolism
|
May 19, 2022
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison
Karan Vadher, Hiren Patel, Reema Mody, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 24, 2020
Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality
Brittany R Lapin, Kevin M Pantalone, Alex Milinovich, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results
Kevin M Pantalone, Kashif Munir, Clinton M Hasenour, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 27, 2019
THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE
Kelly Shibuya, Khawla F Ali, Xinge Ji, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
March 25, 2024
Endocrinology/Primary Care Pharmacy Collaboration vs Endocrinology Care Alone in Patients With Type 2 Diabetes and A1c >9
Courtney R Fornwald, Giavanna Russo-Alvarez, Kevin M Pantalone, et al.
Diabetes, Obesity & Metabolism
|
October 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide
Lai San Tham, Kevin M Pantalone, Kathleen Dungan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 31, 2023
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3
Adie Viljoen, Kevin M Pantalone, Rodolfo J Galindo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 10, 2023
Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019-Related Hospital Outcomes in Patients with Type 2 Diabetes
Derrick Obiri-Yeboah, James Bena, Mahmoud Alwakeel, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Reviews in Endocrine & Metabolic Disorders
|
June 17, 2025
Exploring obesity phenotypes: a longitudinal perspective
Ricardo Rosero-Revelo, Mateo Tamayo, Ricardo Correa, et al.
International Journal of Endocrinology
|
May 5, 2023
Surgical Management of Giant Prolactinomas: A Descriptive Study
Michelle D Lundholm, Divya Yogi-Morren, Kevin M Pantalone, et al.
Diabetes, Obesity & Metabolism
|
May 19, 2022
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison
Karan Vadher, Hiren Patel, Reema Mody, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 24, 2020
Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality
Brittany R Lapin, Kevin M Pantalone, Alex Milinovich, et al.
Diabetes, Obesity & Metabolism
|
August 4, 2020
Cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists: A comparison of study designs, populations and results
Kevin M Pantalone, Kashif Munir, Clinton M Hasenour, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 27, 2019
THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE
Kelly Shibuya, Khawla F Ali, Xinge Ji, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
March 25, 2024
Endocrinology/Primary Care Pharmacy Collaboration vs Endocrinology Care Alone in Patients With Type 2 Diabetes and A1c >9
Courtney R Fornwald, Giavanna Russo-Alvarez, Kevin M Pantalone, et al.
Diabetes, Obesity & Metabolism
|
October 26, 2021
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide
Lai San Tham, Kevin M Pantalone, Kathleen Dungan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 31, 2023
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3
Adie Viljoen, Kevin M Pantalone, Rodolfo J Galindo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 10, 2023
Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019-Related Hospital Outcomes in Patients with Type 2 Diabetes
Derrick Obiri-Yeboah, James Bena, Mahmoud Alwakeel, et al.
Page
of 11